» Articles » PMID: 12122313

Orphanin FQ/nociceptin but Not Ro 65-6570 Inhibits the Expression of Cocaine-induced Conditioned Place Preference

Overview
Journal Behav Pharmacol
Date 2002 Jul 18
PMID 12122313
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The present study investigated the effect of orphanin FQ/nociceptin (OFQ/N), the endogenous ligand of the opioid receptor-like 1 (ORL-1) receptor on the expression of cocaine-induced conditioned place preference (CPP) in rats. To extend this study, the new non-peptidic compound Ro 65-6570 (8-acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4,5]decan-4-one), with agonist activity at ORL-1 receptors, was examined. The influence of both compounds on cocaine-induced hyperactivity was also studied. Our experiments indicated that intracerebroventricular (i.c.v.) injection of OFQ/N, at doses of 10 and 20 microg/rat, significantly suppressed the expression of cocaine-induced place preference. Ro 65-6570 (3 and 6 mg/kg, i.p.) did not change the effect of cocaine, although its acute injection in control rats significantly increased the time spent in the drug-associated compartment of the CPP apparatus. The substances exhibited opposite effects on cocaine-induced hyperactivity (OFQ/N suppressed it but Ro 65-6570 increased it). Our results suggest that the effect of OFQ/N on the expression of cocaine-induced CPP may be a result of its influence on dopamine (DA) neurotransmission in mesolimbic structures. Ro 65-6570 does not share this effect with OFQ/N.

Citing Articles

Pharmacological blockage of NOP receptors decreases ventral tegmental area dopamine neuronal activity through GABA receptor-mediated mechanism.

Petrella M, Borruto A, Curti L, Domi A, Domi E, Xu L Neuropharmacology. 2024; 248:109866.

PMID: 38364970 PMC: 11094429. DOI: 10.1016/j.neuropharm.2024.109866.


Endogenous opioid systems alterations in pain and opioid use disorder.

Higginbotham J, Markovic T, Massaly N, Moron J Front Syst Neurosci. 2022; 16:1014768.

PMID: 36341476 PMC: 9628214. DOI: 10.3389/fnsys.2022.1014768.


Buprenorphine reduces methamphetamine intake and drug seeking behavior activating nociceptin/orphanin FQ peptide receptor in rats.

Wang F, Shen W, Cai Y, Zhang X, Du H, Lai M Front Psychiatry. 2022; 13:983595.

PMID: 36276332 PMC: 9583165. DOI: 10.3389/fpsyt.2022.983595.


Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors.

Neve J, Barlow T, Tourwe D, Bihel F, Simonin F, Ballet S RSC Med Chem. 2021; 12(6):828-870.

PMID: 34223156 PMC: 8221262. DOI: 10.1039/d1md00041a.


The Buprenorphine Analogue BU10119 Attenuates Drug-Primed and Stress-Induced Cocaine Reinstatement in Mice.

Hillhouse T, Olson K, Hallahan J, Rysztak L, Sears B, Meurice C J Pharmacol Exp Ther. 2021; 378(3):287-299.

PMID: 34183434 PMC: 11047085. DOI: 10.1124/jpet.121.000524.